The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNcc Regulatory News (NCC)

Share Price Information for Ncc (NCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 132.20
Bid: 131.80
Ask: 132.60
Change: 0.80 (0.61%)
Spread: 0.80 (0.607%)
Open: 135.00
High: 135.00
Low: 131.60
Prev. Close: 131.40
NCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change to Full Year Results Announcement Date

28 Jul 2021 07:00

RNS Number : 6738G
NCC Group PLC
28 July 2021
 

28 July 2021

NCC Group plcChange to full year results announcement date

NCC Group plc, (LSE: NCC, "NCC Group" or "the Group"), the leading independent global cyber security and resilience advisor, announces that its preliminary results for the financial year ended 31 May 2021 will now take place on Tuesday, 14 September 2021.

From a trading perspective, the Group's outlook remains unchanged and we are focused on seizing the opportunities presented by our growing cybersecurity and resilience markets.

At the end of April 2021, the IFRS Interpretations Committee (IFRIC) published new accounting guidance on the treatment of configuration and customisation costs in Cloud computing arrangements.

 

The practical application of the guidance is still being considered by companies reporting under IFRS, with many considering enhanced disclosure in advance of any adjustments in future periods. While our intention was to provide enhanced disclosure with implementation in the period ended 30 November 2021 (H1 FY22), our auditors have advised us of the requirement to implement this guidance for the year ended 31 May 2021.

 

Initial expectations indicate that the non-cash impact of this new treatment will also affect the years ended 31 May 2019 and 31 May 2020 which were prepared and audited under previous IFRS guidance. Any changes to these prior years will simply reflect the recent clarification in IFRS guidance.

 

The Group has capitalised software and development costs amounting to £6.4m, £10.4m and £7.4m for the years ended 31 May 2019, 31 May 2020 and 31 May 2021 respectively. This mainly includes costs of our multi-year transformation programme, Securing Growth Together, which commenced in 2019. It is expected that a majority of these costs will now require review in light of the new IFRS guidance, together with the resultant amortisation previously recognised to the income statement. This is likely to result in a prior year adjustment on a retrospective basis with the net non-cash impact being classified as an adjusting item. The consequential non-cash impact on the current year ending 31 May 2022 is expected to be neutral or a small net benefit to Adjusted EBIT.

 

Enquiries

NCC Group +44 (0)161 2095432

Adam Palser, CEO

Tim Kowalski, CFO

 

Maitland AMO +44 (0)207 3795151

Neil Bennett

Sam Cartwright

 

 

About NCC Group

 

NCC Group exists to make the world safer and more secure.

 

As global experts in cyber security and risk mitigation, NCC Group is trusted by over 14,000 customers worldwide to protect their most critical assets from the ever-changing threat landscape.

 

With the company's knowledge, experience, and global footprint, it is best placed to help organisations assess, develop and manage their cyber resilience posture.

 

To support its mission, NCC Group continually invests in research and innovation, and is passionate about developing the next generation of cyber scientists.

 

With circa 2,000 colleagues in 12 countries, NCC Group has a significant market presence in North America, Europe and the UK, and a rapidly growing footprint in Asia Pacific with offices in Australia, Japan and Singapore.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORPPUBCMUPGGRM
Date   Source Headline
2nd May 20247:00 amRNSCapital Markets Event for CSMS
1st May 20248:16 amRNSDirector Declaration
24th Apr 20247:00 amRNSAppointment of Joint Broker
18th Apr 20241:12 pmRNSDirector/PDMR Shareholding
16th Apr 202411:29 amRNSDirector/PDMR Shareholding
15th Apr 20244:04 pmRNSHolding(s) in Company
12th Apr 20241:05 pmRNSHolding(s) in Company
9th Apr 20247:00 amRNSCapital Markets Event for Escode
21st Mar 20244:35 pmRNSDirector Declaration
19th Mar 20241:31 pmRNSDirector/PDMR Shareholding
19th Mar 20249:44 amRNSHolding(s) in Company
12th Mar 20245:35 pmRNSHolding(s) in Company
12th Mar 202412:03 pmRNSHolding(s) in Company
20th Feb 202412:36 pmRNSDirector/PDMR Shareholding
31st Jan 20245:30 pmRNSBlock Listing Six Monthly Return
31st Jan 20243:56 pmRNSTR-1: Holding(s) in Company
29th Jan 20245:45 pmRNSChange of Auditor
25th Jan 20247:00 amRNSUnaudited interim results - period ended 30/11/23
18th Jan 20242:58 pmRNSDirector/PDMR Shareholding
21st Dec 20238:02 amRNSStrategic disposal of DetACT
19th Dec 20234:28 pmRNSDirector/PDMR Shareholding
13th Dec 20231:26 pmRNSDirector/PDMR Shareholding
1st Dec 20234:06 pmRNSDirector/PDMR Shareholding
30th Nov 20231:48 pmRNSResults of the 2023 Annual General Meeting
30th Nov 20237:00 amRNSAGM Trading Statement
21st Nov 20235:09 pmRNSBlock Listing Application
21st Nov 20233:51 pmRNSDirector/PDMR Shareholding
31st Oct 20232:13 pmRNSTotal Voting Rights
31st Oct 202311:44 amRNSDirector/PDMR Shareholding
27th Oct 202312:37 pmRNSDirector/PDMR Shareholder Dealing
24th Oct 20235:10 pmRNSHolding(s) in Company
18th Oct 20232:15 pmRNSDirector/PDMR Shareholding
18th Oct 20232:06 pmRNSDirector/PDMR Shareholding
11th Oct 202312:31 pmRNSHolding(s) in Company
11th Oct 202312:21 pmRNSDirector/PDMR Shareholding
10th Oct 20231:07 pmRNSNotice of Annual General Meeting - 2023
10th Oct 202312:52 pmRNSDirector/PDMR Shareholding
5th Oct 202312:58 pmRNSDirector/PDMR Shareholding
4th Oct 20233:26 pmRNSDirector/PDMR Shareholding
3rd Oct 20232:28 pmRNSHolding(s) in Company
28th Sep 20235:07 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSPreliminary unaudited FY 2023 Results
20th Sep 202310:44 amRNSHolding(s) in Company
19th Sep 20233:24 pmRNSDirector/PDMR Shareholding
19th Sep 202311:35 amRNSHolding(s) in Company
19th Sep 202311:31 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSChange to date of Prelim results & trading update
23rd Aug 20232:02 pmRNSHolding(s) in Company
18th Aug 20231:27 pmRNSDirector/PDMR Shareholding
31st Jul 20233:09 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.